Exchange: NASDAQ·Updated 07:58 PM EDT
REPL logo

REPLReplimune Group Inc

$11.58
$0.36
(3.21%)
Today
Closed $11.58
$0.1472
(1.27%)
After Hours
Reported EarningsJun 29
Mkt Cap$972.08M
Vol2.84M

About

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
465

Frequently Asked Questions

What is Market Cap of Replimune Group Inc?
What is the 52-week high for Replimune Group Inc?
What is the 52-week low for Replimune Group Inc?
What is Replimune Group Inc stock price today?
What was Replimune Group Inc stock price yesterday?
What is the PE ratio of Replimune Group Inc?
What is the Price-to-Book ratio of Replimune Group Inc?
What is the 50-day moving average of Replimune Group Inc?
How many employees does Replimune Group Inc have?

Advertisement|Remove ads.